The health and fitness boom is fueling demand for gyms, nutrition, and wellness services. Stocks like SFM, HIMS and DXCM are ...

Ken Griffin, the founder of Citadel, is an influential albeit controversial figure in the investment industry.

DexCom's Q1 2025 earnings show strong growth potential, but cost pressures are impacting margins. Check out why I am lowering my rating on DXCM from buy to hold.

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...

DexCom, Inc. (NASDAQ: DXCM) has once again demonstrated its formidable position in the continuous glucose monitoring (CGM) ...

announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States. With an overall MARD of 8.0% ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and ...

announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States. With an overall MARD of 8.0%,3 Dexcom G7 ...

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

Kimber Powell was diagnosed with type 1 diabetes in October 2023. Her mother, Kelsey, says getting her daughter a diabetic ...

The smaller Mobi pump for more active users was launched in 2024, and the Sigi patch pump is in development. With this range of products, we think it’s likely Tandem can address a wider swath of both ...